Welcome to Roslindale Pediatrics

Tylenol and Ibuprofen Dosage

Posted by on May 13, 2017 in News | Comments Off on Tylenol and Ibuprofen Dosage

ACETAMINOPHEN (TYLENOL)
DOSAGE (every 4-6 hours) :

The enclosed syringe with the infant drops is designed to provide 1.25 ml ( 40 mg) increments.

           WEIGHT     Milligram dosage                             DOSE
             12-17 lb.              80 mg 2.50 ml    
Infant Drops
             18-23 lb.             120 mg 3.75 ml 
Infant Drops
             24-35 lb.             160 mg 5 ml Elixir or 2 chewable tabs
             36-47 lb.             240 mg 7.5 ml Elixir or 3 chewable tabs
             48-59 lb.             320 mg 10 ml Elixir or 4 chewable tabs
             60-71 lb.             400 mg 12.5 ml teaspoons Elixir or 5 chewable tabs
             72- 95 lb             480 mg 6 chewable tabs or 3 Junior Strength Tablets

 

IBUPROFEN ( ADVIL, MOTRIN)
DOSAGE (every 6-8 hours):

WEIGHT

MILLIGRAM
DOSAGE

DOSE

12-21 lb.

50 mg.

1.25 ml Oral Drops OR
½ teaspoon Suspension

22-30 lb.

100mg.

2.50 ml. (2 x 1.25)Oral Drops OR
1 teaspoon Suspension OR
1 Chewable (100mg.) Tablet

31-40 lb.

150mg.

1 ½  teaspoons Suspension OR
1 ½  Chewable (100mg.) Tablets

41-50 lb.

200mg.

2 teaspoons Suspension OR
2 Chewable (100mg.) Tablets

51-60 lb.

250 mg.

2 ½ teaspoons Suspension OR
2 ½ Chewable (100 mg.) Tablets

61-79 lb.

300 mg.

3 teaspoons Suspension OR
3 Chewable (100 mg.) Tablets OR
3 Caplets (100mg.)

80-100 lb.

400 mg.

4 Chewable (100 mg.) Tablets OR
4 Caplets (100 mg.) OR
2 adult tablets (200 mg.)

Read more about what to do for common illnesses.

EPIPEN RECALL

Posted by on April 3, 2017 in News | Comments Off on EPIPEN RECALL

The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies’ voluntary recall
of 13 lots of Mylan’s EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products used for emergency treatment of severe allergic reactions. This recall is due to the potential that these devices may contain a defective part that may result in the devices’ failure to activate. The recalled product was manufactured by Meridian Medical Technologies and distributed by Mylan Specialty.
While the number of reported failures is small, EpiPen products that potentially contain a defective part are being recalled because of the potential for life-threatening risk if a severe allergic reaction goes untreated. Consumers should keep and use their current EpiPens if needed until they get a replacement. Consumers should contact Mylan at 800-796-9526 or customer.service@mylan.com with any questions.
As stated on the product label, consumers should always seek emergency medical help right away after using their EpiPens, particularly if the device did not activate.
At this time, the 13 lots identified – distributed between Dec. 17, 2015, and July 1, 2016 – are the only EpiPen lots impacted by the U.S. recall. Consumers who have EpiPens from lots that are not included in this recall, do not need to replace their EpiPen prior to its expiration date.
Product/Dosage NDC Number Lot Number Expiration Date
EpiPen Jr Auto-Injector, 0.15 mg 49502-501-02 5GN767 April 2017
EpiPen Jr Auto-Injector, 0.15 mg 49502-501-02 5GN773 April 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 5GM631 April 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 5GM640 April 2017
EpiPen Jr Auto-Injector, 0.15 mg 49502-501-02 6GN215 September 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM082 September 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM072 September 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM081 September 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM088 October 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM199 October 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM091 October 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM198 October 2017
EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM087 October 2017

Thank you for your patience!

Posted by on April 3, 2017 in News | Comments Off on Thank you for your patience!

To all our patients,
It has been over 3 months since we have moved into our new location at 2020 Center Street, West Roxbury. We want to thank you all for your patience as we continue to make improvements. We love our new place and want to make sure our patients love it too.
As part of our continuous quality improvement process, we welcome any and all feedback about your experiences with us. Please feel free to contact us at our designated patient feedback email with any concerns that you may have.
Thanks in advance for helping us to continue to provide excellent service!

email: RPApatientfeedback@gmail.com